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In Brief
Telomere dysfunction and DNA damage
cause aging and related chronic
disorders. Xiong et al. show that PGC-1a
disruption drives telomerase TERT
downregulation, telomere malfunction,
and DNA damage, thereby developing
vascular aging and atherosclerosis.
Ectopic expression and induction of
PGC-1a by ALA activate TERT and ARE/
ERE signaling and ameliorate aging-
related pathology.
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Cellular senescence and organismal aging predis-
pose age-related chronic diseases, such as neurode-
generative, metabolic, and cardiovascular disorders.
These diseases emerge coincidently from elevated
oxidative/electrophilic stress, inflammation, mito-
chondrial dysfunction, DNA damage, and telomere
dysfunction and shortening. Mechanistic linkages
are incompletely understood. Here, we show that
ablation of peroxisome proliferator-activated recep-
tor g coactivator-1a (PGC-1a) accelerates vascular
aging and atherosclerosis, coinciding with telomere
dysfunction and shortening and DNA damage.
PGC-1a deletion reduces expression and activity of
telomerase reverse transcriptase (TERT) and in-
creases p53 levels. Ectopic expression of PGC-1a
coactivates TERT transcription and reverses telo-
mere malfunction and DNA damage. Furthermore,
alpha lipoic acid (ALA), a non-dispensable mitochon-
drial cofactor, upregulates PGC-1a-dependent TERT
and the cytoprotective Nrf-2-mediated antioxidant/
electrophile-responsive element (ARE/ERE) sig-
naling cascades, and counteracts high-fat-diet-
induced, age-dependent arteriopathy. These results
illustrate the pivotal importance of PGC-1a in amelio-
rating senescence, aging, and associated chronic
diseases, and may inform novel therapeutic ap-
proaches involving electrophilic specificity.INTRODUCTION
Cellular senescence and organismal aging are implicated in the
onset of chronic diseases of disparate phenotypes with multi-or-
gan dysfunction (Alexander, 2010; Guarente, 2014). Accumula-
tion of senescent cells appears to drive development of multiple
age-relatedmetabolic and cardiovascular diseases. Chronic dis-
eases generally share immune, inflammatory, and metabolic
abnormalities associated with conditions inducing senescence,
including oxidative/electrophilic stress, insulin resistance,
genomic instability, DNA damage, and dysfunction of mitochon-Cell Redria and telomeres (Bachschmid et al., 2013). Vascular aging is
an early stage in the development and progression of atheroscle-
rosis, which is correlated with DNA damage and telomere
dysfunction and shortening (Wang and Bennett, 2012). The
notion that vascular senescence predisposes atherosclerosis in-
forms the possibility that preventing accelerated cellular senes-
cence through pharmacological interventions would be a prom-
ising therapeutic strategy by improving cardiovascular health
and outcomes generally for other age-related chronic diseases.
Telomere dysfunction and DNA damage are important hall-
marks of cellular senescence and organismal aging, which are
correlated with development of multiple chronic inflammatory
diseases, including diabetes, atherosclerosis, and sarcopenia
(Armanios, 2013; Khan et al., 2012). Telomerase reverse tran-
scriptase (TERT) deficiency in mice exhibits dysfunction and
shortening of telomeres, DNA damage, mitochondrial dysfunc-
tion, and elevated oxidative stress (Sahin et al., 2011). Telomere
shortening causes DNA damage during the development of
atherosclerosis (Huzen et al., 2011). However, enforced expres-
sion of TERT protects mitochondria from oxidative DNA damage
(Haendeler et al., 2009). Conditional inactivation of TERT in mice
is associated with age-related, multi-organ dysfunction (Jaskeli-
off et al., 2011). Thus, augmentation of telomerase activity and
mitigation of DNA damage via inducing TERT expression are
posited to be potential targets for therapeutic interventions in
age-related diseases, including atherosclerosis.
Peroxisome proliferator-activated receptor g coactivator-1a
(PGC-1a) enables multiple salutary pathways regulating meta-
bolism, oxidative stress resistance, inflammation, andmitochon-
drial biogenesis and function (Eisele et al., 2013; Patten and
Arany, 2012; Spiegelman, 2013). PGC-1a deficiency has been
implicated in the onset and progression of age-related neurode-
generative disorders (Tellone et al., 2015). Ectopic expression of
PGC-1aDrosophila homolog delays aging and prolongs lifespan
(Rera et al., 2011). However, the actions of PGC-1a and the
mechanisms involved in mitigating mammalian cellular senes-
cence, aging, and related chronic diseases are incompletely un-
derstood. We recently described a novel function for PGC-1a as
a negative regulator of vascular senescence (Xiong et al., 2013).
Functional PGC-1a prevents senescence by enabling transcrip-
tion of the FoxO1-regulated longevity gene sirtuin 1 (SIRT1)
(Xiong et al., 2011). Downregulation of PGC-1a triggered by
TERT deficiency results in mitochondrial compromise, revealing
a link between nuclear telomere dysfunction and mitochondrialports 12, 1391–1399, September 1, 2015 ª2015 The Authors 1391
Figure 1. PGC-1aDeficiency Augments Vascular Aging andAtherosclerosis, Coincidingwith Telomere Dysfunction and Shortening andDNA
Damage through TERT Downregulation
(A) The aortas from PGC-1a+/+ApoE/ and PGC-1a/ApoE/ mice (18-month-old males, standard diet, n = 5) were excised for SA-bG staining.
(B) The aortic arch from PGC-1a/ApoE/ and control mice (18-month-old males, n = 5) was dissected for examination of atherosclerotic lesion formation.
(C) The aortas from PGC-1a/ApoE/ and control mice (12 months old, n = 4) were analyzed for protein expression by western blot (top) or for telomerase
activity by TRAP assay (bottom), respectively.
(D) The aortas from PGC-1a+/+ApoE–/– mice of various ages (12 versus 20 months old, n = 4) were isolated for analysis of protein expression and telomerase
activity.
(E and F) Telomere lengths of aortas (E) isolated from PGC-1+/+ or PGC-1/ApoE+/+ mice or MASMs (F) from PGC-1+/+ or PGC-1/ApoE/ mice were
measured by the Southern blot analysis of TRFs.
(G and H) Oxidative DNA damage in mice aortas (G) or MASMs (H) was measured by competitive ELISA.
(I and J) DNA strand breaks in individual aortic cells isolated from PGC-1a/ApoE+/+ mice aortas (I) or PGC-1a/ApoE/MASMs (J) were detected by alkaline
single-cell gel electrophoresis (comet assays). DNA damage extent was shown as the visual scoring units and tail moment.
(legend continued on next page)
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compromise (Sahin et al., 2011). The roles, however, of PGC-1a
in governing aging-related nuclear telomere dysfunction and
DNA damage are largely unknown.
Here we show that ablation of PGC-1a functionality in apolipo-
protein E (ApoE) knockout mice results in oxidative/electrophilic
stress, telomere dysfunction and shortening, as well as DNA
damage, coinciding with accelerated vascular aging and athero-
sclerosis. The developed telomere compromise and DNA dam-
age are mainly ascribed to the positive feedback signaling inter-
play between TERT reduction and elevated oxidative stress.
Further, ectopic expression of PGC-1a, as well as its induction
by alpha lipoic acid (ALA), increases expression of TERT and
augments the electrophilic nuclear factor erythroid 2 (NF-E2)-
related factor 2 (Nrf-2)-mediated cytoprotective antioxidant/
electrophile-responsive element (ARE/ERE) signaling, while
reducing expression of the DNA damage marker p53. These re-
sults are consistent with the notion that PGC-1a is a primary and
general negative regulator of conditions associated with aging,
and imply a protective role for PGC-1a against aging-related or
mimicked arteriopathy. Enabling PGC-1a signaling cascades
by ALA or other molecules with similar electrophilic profiles
may inform, generally, novel therapeutic strategies for aging-
related chronic diseases.
RESULTS
Deletion of PGC-1a in ApoE Knockout Mice Augments
Vascular Aging and Atherosclerosis in the Context
of Telomere Dysfunction and Shortening as well as
DNA Damage
Vascular senescence is an early onset of atherosclerosis but
causality has not been established (Wang et al., 2014). PGC-
1a expression is decreased in human atherosclerotic plaque
(McCarthy et al., 2013). Others and we demonstrated recently
that PGC-1a-deficient mice developed vascular senescence,
which occurred mainly in the vascular smooth muscle cells
(VSMCs) (Kro¨ller-Scho¨n et al., 2013; Xiong et al., 2013). The find-
ings infer that PGC-1amay protect against aging-related athero-
sclerosis. The ApoE-deficient mouse has been the most widely
used animal model of atherosclerosis, because it exhibits
increased sensitivity to oxidative stress and inflammation and
rapidly develops spontaneous atherosclerotic lesions similar to
those observed in humans. To investigate the role of PGC-1a
in atherosclerosis progression, we therefore developed the
PGC-1a/ApoE/ model. The PGC-1a/ApoE/ mice that
were fed a standard chow diet for 18–20 months developed
dramatically more severe vascular senescence (Figures 1A and
S1A) and atherosclerotic lesions (Figures 1B and S1B) than con-
trol PGC-1a+/+ApoE/mice. Therewas no significant difference
in atherosclerosis phenotypes between 6-month-old PGC-
1a/ApoE/ and control mice (Figure S1C). PGC-1a disruption
in young (2-month-old) ApoE/ mice did not exhibit increased(K–P) PGC-1a/ApoE/ MASMs were infected with Ad.PGC-1a constitutive a
analysis of senescencewas performed using fluorescein di-b-D-galactopyranosid
described in the Experimental Procedures. DNA strand breaks (N) in individual c
oxidative DNA damage by measuring 8-OH-dG production (O). Protein expressio
indicated; ns, no statistically significant difference. All data represent mean ± SE
Cell Reatherosclerotic lesions compared with littermate controls (Stein
et al., 2010). Thus, the athero-protective role of PGC-1a appears
to be age-dependent.
We posited that PGC-1a deletion impacts the function and
length of telomeres and DNA damage. As predicted, expression
and activity of TERT were significantly reduced in aortas from
PGC-1a/ApoE/ mice compared with controls (Figure 1C).
PGC-1a deficiency also was associated with enhanced senes-
cence as reflected in elevated levels of p53, a marker of senes-
cence and DNA damage (Figure 1C). Expression of PGC-1a and
TERT was markedly decreased in the aortas from 20-month-old
mice compared with 12-month-old mice, while p53 levels were
elevated in the older group (Figure 1D). The decreased telome-
rase activity is attributable to reduced TERT expression. Further,
vascular senescence progressed with age and inversely corre-
lated with the expression levels of PGC-1a (Figure S1D). Speci-
ficity of TERT antibody was corroborated by knockdown
efficiency of TERT using increasing doses of SMARTpool TERT
small interfering RNA (siRNA) in primary mouse aortic smooth
muscle cells (MASMs) (Figure S1E). Southern blot analysis of ter-
minal restriction fragments (TRFs) indicated that telomere length
was significantly shortened in PGC-1a-deficient aortas (Figures
1E and S1F) and MASMs (Figures 1F and S1G) compared with
controls. These data indicate that PGC-1a regulates telomere
function and length.
We speculated that elevated oxidative/electrophilic stress and
DNA damage were present in PGC-1a/ApoE/ groups. Pri-
mary PGC-1a deficiency resulted in moderate increases of intra-
cellular and mitochondrial reactive oxygen species (ROS) levels
(Figures S1H and S1I). 8-hydroxydeoxyguanosine (8-OH-dG) is
one of the oxidative DNA damage by-products and a ubiquitous
marker of oxidative stress. We observed that 8-OH-dG produc-
tion was augmented in PGC-1a-deficient aortas (Figure 1G) and
MASMs (Figure 1H) compared with controls. To examine if PGC-
1a disruption causes DNA strand breaks, we performed alkaline
comet assays, which detect single- and double-strand DNA
breaks under alkaline conditions. PGC-1a-deficient aortic cells
(Figure 1I) and MASMs (Figure 1J) exhibited enhanced DNA
strand breaks compared with controls by measurement of
comet tail moment. Collectively, these results inform an impor-
tant role for PGC-1a in mitigating oxidative DNA damage and
strand breaks.
Reduction in TERT Expression Is Required for PGC-1a
Deficiency-Triggered Telomere Dysfunction and
Shortening as well as DNA Damage
To validate whether TERT reduction directly contributes to the
effect of PGC-1a ablation, we performed rescue experiments
in PGC-1a-deficient MASMs. Enforced expression of a PGC-
1a constitutive active form (PGC-1a-CA: PGC-1a-S570A) (Li
et al., 2007; Xiong et al., 2010, 2013) or TERT reversed the
established senescence phenotype (Figure 1K) and restoredctive form (PGC-1a-CA), Ad.TERT, or control Ad.LacZ for 1 day. Quantitative
e (FDG) (K). Telomerase activity (L) and telomere length (M) were determined as
ells were analyzed by comet assays. Genomic DNA was used for analysis of
n was determined by western blot (P). *p < 0.05, **p < 0.01 versus control or as
M. Also see Figure S1.
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telomerase activities (Figure 1L) and telomere length (Figures 1M
and S1J). Further, accumulated DNA damage (Figure 1N) and 8-
OH-dG production (Figure 1O) were entirely blocked. Consis-
tently, enforced expression of PGC-1a-CA restored reduced
TERT levels and prevented an increase in p53 protein levels (Fig-
ure 1P). Ectopic expression of TERT blocked p53 upregulation,
but had no effects on PGC-1a levels (Figure 1P). These findings
support the notion that PGC-1a disruption-induced telomere
dysfunction and DNA damage are mainly due to TERT
downregulation.
Augmentation of Oxidative Stress Is Implicated
in PGC-1a Ablation-Triggered Telomere Dysfunction
and Shortening as well as DNA Damage
Levels of oxidative stress are generally in opposite directions to
telomere dysfunction and DNA damage in PGC-1a-deficient
systems. To investigate whether and how elevated oxidative
stress per se contributes to the developed phenotypes, we
analyzed the effects of PGC-1a depletion under the conditions
of normal or quasi-normal levels of ROS. N-acetylcysteine
(NAC) treatments (1 and 5mM) were sufficient to fix the oxidative
stress to normal or quasi-normal levels in PGC-1a/ApoE/
MASMs (Figure 2A). Even under normal ROS conditions, ablation
of PGC-1a enabled senescence, while NAC ameliorated it (Fig-
ure 2B). Notably, NAC repression of oxidative stress increased
TERT protein levels (Figure 2C), suggesting that PGC-1a disrup-
tion-induced oxidative stress may reduce TERT levels possibly
via modulating protein stability by a post-translational modifica-
tion mechanism. Moreover, PGC-1a depletion significantly
reduced TERT expression compared with wild-type control un-
der conditions of NAC-mediated ROS inhibition (Figure 2C),
implying that a ROS-independent transcriptional mechanism
also is involved. However, NAC-mediated suppression of oxida-
tive stress in PGC-1a/ApoE/ MASMs did not decrease p53
levels (Figure 2C), implying that the elevated oxidative stress is
not the cause of p53 upregulation. PGC-1a loss decreased telo-
merase activity via a reduction in TERT expression, while NAC-
mediated ROS inhibition augmented TERT activity due to
increased TERT expression (Figure 2D).
Further, PGC-1a disruption-induced 8-OH-dG production
(Figure 2E) and DNA strand breaks (Figure 2F) were suppressed,
but not prevented, by NAC treatment, indicating that the
elevated oxidative stress is partially implicated in the accumula-
tion of DNA damage. Under normal ROS conditions, PGC-1a
loss still promoted DNA damage (Figure 2F). Phosphorylation
of histone H2AX is an indicator of DNA double-strand breaks
(DSBs), which lead to the development of senescence and aging
(Sedelnikova et al., 2004). Phosphorylated H2AX (g-H2AX) forms
g-foci adjacent to DNA DSB sites (Kinner et al., 2008). Immuno-
staining assay revealed that the loss of PGC-1a markedly
increased numbers of g-H2AX foci compared with control (Fig-
ure 2G) in the absence of NAC. The accumulation of g-H2AX
foci in PGC-1a/ApoE/ MASMs was moderately attenuated
by NAC treatment, implying that PGC-1a disruption-triggered
DSBs partially depend on the elevated oxidative stress.
To analyze whether the developed DNA damage foci occur at
telomeres, we performed combined g-H2AX immunostaining
and telomere fluorescence in situ hybridization (FISH) experi-1394 Cell Reports 12, 1391–1399, September 1, 2015 ª2015 The Auments using anti-g-H2AX antibody and Cy3-labeled telomere-
specific peptide nucleic acid (PNA) probes. Colocalization be-
tween g-H2AX foci and telomeres indicates that PGC-1a loss
in PGC-1a/ApoE/ MASMs induced both telomeric and
non-telomeric DNA damage (Figures 2H and 2I). Interestingly,
the accumulation of g-H2AX foci in the presence of 5 mM NAC
was mainly telomeric (Figures 2H and 2I), implying that the
non-telomeric random g-H2AX foci caused by PGC-1a deletion
are likely ascribed to the elevated oxidative stress. To corrobo-
rate whether telomeric DNA damage triggered by PGC-1a loss
affected telomere length, we next performed the quantitative
telomere FISH analysis. PGC-1a deletion resulted in telomere
shortening compared with control in the absence and presence
of NAC (Figure 2J). The extent of telomere shortening in PGC-
1a/ApoE/ MASMs was attenuated by NAC treatment, sug-
gesting that oxidative stress moderately contributes to telomere
shortening. These data indicate that ablation of PGC-1a leads to
telomere dysfunction and shortening as well as telomeric and
non-telomeric DNA damage, partially through the augmented
oxidative stress.
ALA Enables PGC-1a-Modulated TERT and ARE/ERE
Signaling Cascades
Ectopic expression of TERT in adult and old mice increases
health span and lifespan without increasing cancer incidence
(Bernardes de Jesus et al., 2012). We posited that PGC-1a
directly modulates TERT expression at a transcriptional level.
To test this hypothesis, we analyzed the 3-kb promoter region
of the rat, mouse, and human TERT homologs, and we found
that putative DNA-binding elements of transcription factors,
including PPAR-gamma, FoxO1, Nrf-2, p53, CREB, ER-a/
ERR-a, and YY-1 (Yin and Yang 1), are present and highly and
evolutionarily conserved (Figure S2A). Expression of these tran-
scription factors is regulated generally by PGC-1a (Patten and
Arany, 2012), implying that PGC-1a could directly enable
expression and activities of TERT. In fact, overexpression of
PGC-1a-CA in rat aortic smooth muscle cells (RASMs) dose-
dependently increased TERT expression and activities, while
reducing p53 levels (Figures 3A–3C). The enabled telomerase
activity is likely due to the elevation of TERT expression. Further,
enforced expression of PGC-1a-CA upregulated multiple salu-
tary pathways, including Nrf-1, Nrf-2, mitochondrial transcription
factor A (TFAM), SIRT1, heme oxygenase-1 (HO-1), and MnSOD
(Figure S2B). Many of these molecules mitigate oxidative/elec-
trophilic stress, inflammation, and metabolic and mitochondrial
dysfunction. In particular, Nrf-2 and HO-1 are pivotal for ARE/
ERE adaptive electrophilic responses (Vriend and Reiter, 2015).
These results intuitively suggest that saving or rescuing PGC-
1a expression could have salutary effects on general health.
ALA, an indispensible mitochondrial cofactor (Packer and Ca-
denas, 2011), upregulates PGC-1a expression and mitigates the
development of atherosclerosis (Zhang et al., 2008). The detailed
mechanisms are not well understood. We posited that ALA is a
potent activator of PGC-1a-modulated TERT and ARE/ERE
signaling cascades, thereby inhibiting oxidative/electrophilic
stress and DNA damage while improving telomere function. To
test this hypothesis, we examined the effects of ALA on PGC-
1a-TERT signaling and telomerase activity. We found thatthors
Figure 2. PGC-1a Deficiency Leads to Telomere Dysfunction and Shortening as well as DNA Damage under Normal Levels of Oxidative
Stress
(A)MASMs fromPGC-1a/ApoE/mice in 12-well culture plates were treatedwith 1 and 5mMNACor control for 2 days.Measurement of ROSwas performed.
(B–D) MASMs from PGC-1a/ApoE/mice in six-well culture plates were treated with 1 and 5 mM NAC or control for 2 days. SA-b-gal activity was analyzed
using FDG probes (B). Protein expression was analyzed (C). Telomerase activity was determined (D).
(E and F) MASMs from PGC-1a/ApoE/mice were treated with 1 and 5 mMNAC or control for 2 days. 8-OH-dG production of genomic DNA was determined
by ELISA (E). DNA strand breaks were analyzed by comet assays (F); DNA damage extent was quantified by tail moment.
(G) PGC-1a/ApoE/ MASMs were treated with 1 and 5 mM NAC or control for 2 days. Immunostaining with anti-g-H2AX antibody was performed. Repre-
sentative images show endogenous g-H2AX foci (green). DAPI staining (blue) indicates nucleic DNA. Scale bar, 20 mm.
(H and I) PGC-1a+/+ApoE/ and PGC-1a/ApoE/ MASMs were treated with 5 mM NAC or control for 2 days. Combined g-H2AX immunostaining and
telomere FISH experiments were performed. White arrows on the representative images (H) indicate colocalization of g-H2AX foci (green) and telomeric DNA
(red). Colocalized foci are amplified (right). Scale bar, 20 mm. (I) Mean number of both telomeric foci and non-telomeric foci in each group was calculated.
(J) PGC-1a/ApoE/MASMs were treated with 5 mMNAC or control for 2 days. Telomere-FISH was performed as described in the Experimental Procedures.
*p < 0.05, **p < 0.01 versus control or as indicated; ns, no statistically significant difference. Values are mean ± SEM of n = 300.
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Figure 3. ALA Enables PGC-1a-Dependent TERT and ARE/ERE Signaling
(A–C) Increasing amounts of Ad.PGC-1a-CA or Ad.LacZ (control) were transduced into RASMs for 24 hr. Protein expression was determined by western blot (A).
Telomerase activity was analyzed by TRAPmethods (B). Amplification products of telomeric repeats were subjected to electrophoresis on a 10% nondenaturing
polyacrylamide gel (C).
(D) RASMs were treated with increasing doses of ALA for 1 day. Protein expression was determined by western blot. Telomerase activity was analyzed.
(E) ApoE/mice (6-month-oldmales, n = 4–6) were treated with an i.p. injection of increasing doses of ALA for 7 days. Protein expression and telomerase activity
of aortas were analyzed as described before.
(F) MASMs from PGC-1a/ApoE/ and control mice were treated with or without ALA for 1 day. Protein expression and telomerase activity were analyzed.
*p < 0.05 versus control or as indicated; ns, no statistically significant difference. All data represent mean ± SEM. Also see Figure S2.100 mM ALA treatment increased expression of PGC-1a and
TERT, while decreasing p53 levels in dose- and time-dependent
manners in VSMCs (Figures 3D and S2C). ALA treatment ex-
hibited a prolonged stimulatory effect on telomerase activity
(Figure S2D), which is consistent with augmented TERT expres-
sion. In support of this notion, ALA robustly augmented expres-
sion of ARE/ERE signalingmolecules, including Nrf-2, HO-1, and
catalase (Figures S2C and S2E). These data were reproducible
in vivo. Intraperitoneal (i.p.) injection of increasing doses of
ALA elevated the expression of PGC-1a-modulated TERT and
ARE/ERE signaling molecules while decreasing p53 expression
(Figures 3E and S2F). Importantly, the augmentation in expres-
sion and activity of TERT and ARE/ERE molecules and the
reduction in p53 levels were abolished in PGC-1a/ MASMs,
indicating that PGC-1a is necessary for the salutary electro-
philic-like effects of ALA (Figures 3F and S2G). These results
suggest that ALA exhibits electrophile-like function in its induc-
tion of PGC-1a-modulated TERT and Nrf-2-mediated ARE/ERE
signaling, which has been known to antagonize electrophilic/
oxidative stress, inflammation, aging, and cancer (Levonen
et al., 2014).1396 Cell Reports 12, 1391–1399, September 1, 2015 ª2015 The AuEnabling PGC-1a-Modulated TERT Signaling by ALA
Blocks High-Fat Diet-Induced Telomere Dysfunction
and DNA Damage and Ameliorates Vascular Aging and
Atherosclerosis
The cyclic AMP (cAMP) response element-binding protein
(CREB) is an important vasculoprotective transcription factor
that generally enables PGC-1a transcription (St-Pierre et al.,
2006). Vascular content of CREB is decreased in numerous ro-
dent aging models of atherosclerosis (Reusch and Klemm,
2003). We found that ALA robustly stimulated cAMP production
in VSMCs and mice aortas (Figures S3A and S3B). Further, ALA
treatment stimulated CREB phosphorylation at Ser133, an acti-
vation site for CREB activity, and had a prolonged effect for
2 days (Figure S3C). However, ALA did not alter CREB expres-
sion. The results were reproducible in vivo (Figure S3D). Alto-
gether, ALA enabled PGC-1a transcription possibly via CREB
activation.
High-fat diet (HFD) is a major risk factor for vascular aging and
atherosclerotic diseases (Wang and Bennett, 2012). We posited
that HFD decreases CREB activity and PGC-1a-TERT signaling
and accelerates vascular aging and atherosclerosis. Feeding athors
Figure 4. ALA-Induced Inhibition of Telomere Dysfunction and DNA Damage Ameliorates HFD-Induced Vascular Aging and Atherosclerosis
(A) PGC-1a+/+ApoE/micewere fed a HFD or a low-fat diet (LFD) for 2 and 4weeks. CREB phosphorylation and protein expression in aortas were determined by
western blot.
(B–F) PGC-1a+/+ApoE/mice (5–6-month-old males, n = 3–5) were pretreated with ALA by oral administration for 5 days and fed a LFD containing 4% fat or an
atherogenic diet containing 16% fat for 2 weeks. Protein expression was determined by western blot.
(G–I) PGC-1a+/+ApoE/mice (7–8-month-old males, n = 3–5) fed a LFD or an atherogenic diet were orally administered ALA for 7 days. Telomerase activity was
determined (G). 8-OH-dG production was analyzed by ELISA (H). DNA damage extent was analyzed by comet assays and quantified by the mean tail moment (I).
(J and K) PGC-1a+/+ApoE/mice (5–6-month-old males, n = 6–7) were pretreated with ALA by i.p. injection for 5 days and fed a LFD or an atherogenic diet for
4 weeks. Vascular aging was quantified by FDG assay (J). Atherosclerotic lesions were quantified by ImageJ (K). *p < 0.05, **p < 0.01; ns, no significant difference.
All data represent mean ± SEM. Also see Figure S3.HFD for 2 and 4 weeks decreased CREB phosphorylation, but
not protein expression, implying that HFD reduces CREB func-
tion only (Figures 4A and S3E). However, HFD reduced PGC-
1a and TERT expression while upregulating p53 levels (Figures
4A and S3E). Reduction in the expression of PGC-1a, TERT,
and SIRT1 by HFD was prevented by ALA (Figures 4B–4E).
HFD-induced p53 expression also was blocked (Figure 4F).
Further, HFD-induced reduction in telomerase activity was pre-
vented by ALA (Figure 4G), which is consistent with changes in
TERT expression levels. Elevation of 8-OH-dG production by
HFD was dramatically blocked in aortas, inferring that ALA miti-
gated DNA damage (Figure 4H). Comet assays revealed that the
accumulated DNA strand breaks were decreased (Figures 4I and
S3F). We next investigated whether ALA ameliorates HFD-
induced vascular aging and atherosclerosis. As shown in Figures
4J and 4K, increased vascular aging and atherosclerosis were
remarkably inhibited by ALA treatment. Collectively, these re-
sults show that ALA ameliorates the accelerated vascular aging
and atherosclerosis, possibly by blocking HFD-induced reduc-
tion of the CREB-PGC-1a-TERT signaling cascade.Cell ReDISCUSSION
PGC-1a ablation in ApoE knockout mice drives telomere mal-
function and shortening as well as telomeric and non-telomeric
DNA damage, thereby promoting vascular aging and atheroscle-
rosis. The effects of PGC-1a ablation are mediated by TERT
reduction and elevated ROS. The developed telomere
malfunction and shortening as well as DNA damage in PGC-
1a/ApoE/ MASMs were moderately ameliorated by NAC-
mediated ROS inhibition, indicating that these outcomes are
partially ascribed to the augmented oxidative stress (Figure 2).
Moreover, even under conditions of normal ROS levels, the
impact of PGC-1a ablation continues to be manifested by the
extent of TERT downregulation, telomere dysfunction, and telo-
meric DNA damage. These results indicate that TERT reduction
and augmented oxidative stress are the dominant mechanisms
underlying PGC-1a deletion-induced telomere malfunction,
DNA damage, cellular senescence, and related pathological
conditions. In fact, our data demonstrate that NAC inhibition of
the elevated oxidative stress increases TERT protein levelsports 12, 1391–1399, September 1, 2015 ª2015 The Authors 1397
(Figure 2C), suggesting that PGC-1a loss-induced ROS produc-
tion also drives TERT downregulation possibly via modulating
protein stability. Conversely, depletion of TERT further promotes
PGC-1a reduction and ROS production via a positive feedback
loop mechanism (Sahin et al., 2011). These results suggest
that a chicken-and-egg conundrum exists in the feedback loop
interplay between PGC-1a and TERT signaling in protecting
against senescence and aging processes.
Here our data demonstrate that PGC-1a directly increases
TERT expression (Figure 3A). Further, we found that there are
multiple conserved PGC-1a-coactivated DNA-binding ele-
ments of transcriptional factors (PPAR-gamma, FoxO1, Nrf-2,
CREB, p53, and others) within the rat, mouse, and human
TERT promoter regions (Figure S2A), informing that PGC-1a
modulates TERT expression at a transcriptional level. The
detailed identification of the specific transcriptional factors
mediating PGC-1a-modulated TERT expression will provide
valuable information on the linkage between PGC-1a and
TERT signaling. Conversely, ectopic expression of TERT does
not affect PGC-1a protein levels (Sahin et al., 2011). These ob-
servations suggest that PGC-1a may be a primary and general
modulator of TERT expression and aging conditions during the
development and progression of organismal aging and related
pathologies.
We have shown, as have others, that ALA stimulates PGC1-a
co-transcriptional function in a broad spectrum of genes associ-
ated with health and resistance to disease and aging in animal
models of diverse phenotypes. Results of efforts to apply this po-
tential therapeutic strategy in man have been generally unsuc-
cessful. The inability to translate the approach is multifactorial
and includes issues concerning patent protection, bioavail-
ability, perceived pharmacokinetic limitations, and, particularly,
lack of mechanistic insights in models that permit a coherent un-
derstanding of the organization of the signaling pathways and
endpoints involved, the major problem addressed here. We
show that ALA behaves like an electrophile in the induction of
PGC-1a-modulated TERT and ARE/ERE signaling cascades
and protects against telomere malfunction, oxidative stress,
and DNA damage, thereby ameliorating HFD-exacerbated
vascular aging and atherosclerosis. Taken together, the findings
here support the notion that PGC-1a in an appropriate electro-
philic environment organizes specific signaling pathways that
inform new drug targets and that mitigate premature aging and
related chronic diseases.
EXPERIMENTAL PROCEDURES
Extensive experimental details are described in the Supplemental Experi-
mental Procedures.
Mice
ApoE/ mice (C57BL/6 background) were purchased from Jackson Labora-
tory. PGC-1a/ApoE/ mice were generated and genotyped by crossing
PGC-1a/ mice and ApoE/ mice. Genotyping of PGC-1a/ApoE/
mice was performed by PCR using tail DNA. The third and fourth generations
of offspring were used for senescence and atherosclerosis studies. All studies
were done in male mice. All experimental male mice were older than 3months.
Animals with gender- and age-matched littermates were randomly included in
experiments. No animals had to be excluded because of illness after experi-
ments. Animal experiments and euthanasia protocols were performed in strict1398 Cell Reports 12, 1391–1399, September 1, 2015 ª2015 The Aucompliance with the NIH guidelines for humane treatment and approved by the
Institutional Animal Care and Use Committee of Emory University.
Detection of Telomerase Activity
Telomerase activity was determined by telomeric repeat amplification protocol
(TRAP) assay (Wright et al., 1995). Briefly, cell pellets were lysed in CHAPS
lysis buffer containing ribonuclease inhibitor and incubated for 30 min at
4C. Cell extract (1 mg) was mixed with TRAPeze reaction mix containing telo-
merase substrate (TS) primer, fluorescein-labeled RP (reverse) primer, control
template, and sulforhodamine-labeled control K2 primer. Extension of TS
primers was performed at 30C for 30 min and followed by PCR amplification.
TRAP products from the same experiment were analyzed for quantification of
telomerase activity by measuring fluorescence on a fluorescence plate reader.
The relative telomerase activity was normalized by the ratio of the net fluores-
cein to sulforhodamine (internal control) and expressed as a percentage of
wild-type value. Mean values ± SEM were calculated from three independent
assays.
Statistical Analysis
Data were analyzed by two-tailed unpaired Student’s t test for comparisons of
two groups or one-way ANOVA of the repeated experiments followed by the
Tukey’s post hoc pairwise multiple comparisons when appropriate with Prism
5 (GraphPad). A p value of < 0.05 was considered significant. For all bar
graphs, the mean ± SEM is plotted. All in vitro experiments were repeated at
least three times unless otherwise indicated.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and three figures and can be found with this article online at http://dx.doi.
org/10.1016/j.celrep.2015.07.047.
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